Just launched · October 2026—Rankings get sharper with every edition.Spotted an error?Tell us →
Sign in / Register

Terramera

ActiveOn the Biological inputs Radar · not ranked

Develops plant-based and bio-derived crop protection formulations and a technology that lets growers cut synthetic pesticide doses while keeping efficacy.

HQCanada
Last roundSeries B extension · 2020

Why Terramera is not ranked yet

How the Radar works →

The Radar lists every known eligible company, sorted by date of last round, with no AI judgement. Terramera enters the ranking once its public data is sufficient for the AI to estimate it. Next Biological inputs worldwide edition: 12 Feb 2027.

Funding history

DateRoundAmountTypeInvestors
2020Series B extension—Equity—

CAD 4.6M.

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Biological inputs · worldwideRadar—Edition 0 · Oct 202612 Feb 2027

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Terramera as a PDF. It must answer at least one of these four questions, and stick to them:

ValuationWhat is Terramera worth?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Who should it acquireAcquisition targets, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Comparable companies in biological inputs

Full biological inputs ranking →

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.